#ExistRefRangeSet>
Reference Interval:
#ExistRefRangeTable> | Test Number
| Components
| Reference Interval
| | | Uroporphyrin
| 0-4 µmol/mol crt
| | | Heptacarboxylate Porphyrin
| 0-2 µmol/mol crt
| | | Coproporphyrin I
| 0-6 µmol/mol crt
| | | Coproporphyrin III
| 0-14 µmol/mol crt
| | | Porphobilinogen, Urine
| 0.0-8.8 µmol/L
| | | Porphobilinogen, Urine (24-hour)
| 0.0-11.0 µmol/d
| | 0020473 | Creatinine, 24-Hour Urine
| | Age
| Male
| Female
| | 3-8 years
| 140-700 mg/d
| 140-700 mg/d
| | 9-12 years
| 300-1300 mg/d
| 300-1300 mg/d
| | 13-17 years
| 500-2300 mg/d
| 400-1600 mg/d
| | 18-50 years
| 1000-2500 mg/d
| 700-1600 mg/d
| | 51-80 years
| 800-2100 mg/d
| 500-1400 mg/d
| | 81 years and older
| 600-2000 mg/d
| 400-1300 mg/d
|
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Results are normalized to creatinine concentration and reported as a ratio of amounts (micromoles of porphyrin/moles of creatinine).
See Compliance Statement B: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
Urine porphyrins are useful for the evaluation of cutaneous photosensitivity to exclude porphyria cutanea tarda (PCT). Urine porphobilinogen (PBG) is useful for the evaluation of neurologic and/or psychiatric symptoms to exclude acute porphyrias such as acute intermittent porphyria (AIP).
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
84120; 84110
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
PBG (Porphyrins & Porphobilinogen (PBG), Urine), Porphyrins, Quantitative, 24-Hour Urine (Porphyrins & Porphobilinogen (PBG), Urine), Urine Quantitative (Porphyrins & Porphobilinogen (PBG), Urine) |
*ExistCrossReferences>